ADVERSE EVENTS DURING TREATMENT OF PATIENTS SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS

ADVERSE EVENTS DURING TREATMENT OF PATIENTS SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS

Objective: to perform retrospective analysis of the ranges, structure, degree of severity and time of development of adverse events in tuberculosis patients with multiple drug resistance on treatment and to assess their impact on chemotherapy duration Results. Totally, 1387 adverse events were regis...

Full description

Bibliographic Details
Main Authors:	D. Yu. Schegertsov, O. V. Filinyuk, L. N. Buynova, N. A. Zemlyanaya, N. N. Kabanets, A. S. Alliluev
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2018-04-01
Series:	Туберкулез и болезни лёгких
Subjects:	tuberculosis multiple drug resistance adverse events intestinal, dermatological and visual reactions hepatotoxicity ototoxicity hypothyrosis nephrotoxicity peripheral neuropathy
Online Access:	https://www.tibl-journal.com/jour/article/view/1102

Similar Items

Nephrotoxic characteristics of anti-tuberculosis drugs
by: G. N. Mozhokina, et al.
Published: (2019-11-01)

Acetophenone protection against cisplatin-induced end-organ damage
by: Brian Geohagen, et al.
Published: (2023-01-01)

Frequency, management and impact of adverse events on treatment outcomes in patients with multidrug resistant tuberculosis in Balochistan, Pakistan
by: Sara Rafique, et al.
Published: (2024-12-01)

Tolerability and Efficacy of Chemotherapy Containing Bedaquiline in Patients with Multiple Drug Resistant Pulmonary Tuberculosis
by: O. V. Filinyuk, et al.
Published: (2022-10-01)

Arterial hypertension and thyroid function compensation: pharmacotherapy aspects
by: G. B. Selivanova
Published: (2008-06-01)

Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study
by: Workineh Shibeshi, et al.
Published: (2019-05-01)

Comparative effectiveness of antihypertensive agents in hypothyreosis patients
by: E. T. Dykhne, et al.
Published: (2008-02-01)

An adverse events potential costs analysis based on Drug Programs in Poland. Dermatology focus
by: Szkultecka-Debek Monika, et al.
Published: (2014-09-01)

TRPV1: A Potential Drug Target for Treating Various Diseases
by: Rafael Brito, et al.
Published: (2014-05-01)

Toxicity evaluation of processing Evodiae fructus based on intestinal microbiota
by: Xuejuan Liang, et al.
Published: (2024-02-01)

Amelioration Of Doxorubicin-Induced Liver And Kidney Toxicities By Nicorandil Alone And Co-Administered With Prednisolone And Diltiazem
by: Abidemi J. Akindele, et al.
Published: (2019-12-01)

Time course of cisplatin-induced nephrotoxicity and hepatotoxicity
by: Zahra Pezeshki, et al.
Published: (2017-07-01)

The influence of poisoning with patulin on activity of acid phosphatase, cathepsin B and D in mice kidneys and livers
by: Andrzej Borzęcki, et al.
Published: (2020-09-01)

Aminoglycoside-Induced Cochleotoxicity: A Review
by: Meiyan Jiang, et al.
Published: (2017-10-01)

Adverse drug reactions of first-line antitubercular drugs: A retrospective study on characteristics, management, factors, and impacts
by: Ai Ling Oh, et al.
Published: (2024-10-01)

CURRENT APPROACHES TO TEACHING TUBERCULOSIS CONTROL WHEN INTRODUCING FEDERAL STATE EDUCATIONAL STANDARD OF HIGHER EDUCATION
by: O. V. Filinyuk, et al.
Published: (2017-04-01)

IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events
by: Stephanie L. Gu, et al.
Published: (2023-11-01)

The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish model
by: Jaime N Wertman, et al.
Published: (2020-07-01)

Arterial hypertension in hypothyrosis: severity and state of renin-aldosteron system
by: G. B. Selivanova, et al.
Published: (2004-06-01)

Arterial hypertension severity and blood lipid profile in thyrotoxicosis and hypothyrosis
by: P. Kh. Dzhanashiya, et al.
Published: (2004-08-01)

THE PECULIARITIES OF PERIOPERATIVE CLINICAL CHARACTERISTICS OF PATIENTS WITH GENITAL ENDOMETRIOSIS ASSOCIATED WITH HYPOTHYROSIS
by: T. Struk, et al.
Published: (2020-03-01)

PGC-1α-mediated imbalance of mitochondria-lipid droplet homeostasis in neomycin-induced ototoxicity and nephrotoxicity
by: Bin Chen, et al.
Published: (2024-10-01)

Hearing impairment in patients with tuberculosis from Northeast Brazil Alteração auditiva em pacientes com tuberculose no nordeste do Brasil
by: Maria Luiza Lopes Timóteo de Lima, et al.
Published: (2006-04-01)

Potential Impact of the Involvement of Clinical Pharmacists in Antimicrobial Stewardship Programs on the Incidence of Antimicrobial-Related Adverse Events in Hospitalized Patients: A Multicenter Retrospective Study
by: Yewon Suh, et al.
Published: (2021-07-01)

Protective effect of aqueous extract of Lophira lanceolata leaf against cisplatin-induced hepatorenal injuries and dyslipidemia in Wistar rats
by: Raphael John Ogbe, et al.
Published: (2020-01-01)

Frequency and characteristics of adverse events caused by anti-tuberculosis drugs in pulmonary tuberculosis patients with diabetes myelitis
by: O. G. Komissarova, et al.
Published: (2020-03-01)

TO DISCONTINUE OR TO WAIT?: INDICATIONS FOR DISCONTINUATION OF ANTI-TUBERCULOSIS DRUGS DUE TO ADVERSE EVENTS
by: D. A. Ivаnovа, et al.
Published: (2018-03-01)

The Risk and Clinical Implications of Antibiotic-Associated Acute Kidney Injury: A Review of the Clinical Data for Agents with Signals from the Food and Drug Administration’s Adverse Event Reporting System (FAERS) Database
by: Kalin M. Clifford, et al.
Published: (2022-10-01)

Hepatoprotective Effect of Coenzyme Q10 in Rats with Diclofenac Toxicity
by: Z Abed Al-Kareem, et al.
Published: (2022-04-01)

A Review of Bullous Dermatologic Adverse Events Associated with Anti-Cancer Therapy
by: Rose Parisi, et al.
Published: (2023-01-01)

Adverse event reporting practices in drug-resistant tuberculosis facilities across South Africa
by: Razia Gaida, et al.
Published: (2023-12-01)

Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency
by: Edit Dósa, et al.
Published: (2017-10-01)

The Safety Profile of Single Daily Dose of Aminoglycosides in Comparison with Multiple Daily Dose
by: Amanj A. Baker, et al.
Published: (2017-03-01)

Are statins really wonder drugs?
by: Harpreet Singh Grover, et al.
Published: (2014-12-01)

Differential Dermatologic Adverse Events Associated With Checkpoint Inhibitor Monotherapy and Combination Therapy: A Meta-Analysis of Randomized Control Trials
by: Yang Ge, et al.
Published: (2021-07-01)

Safety evaluation of Sapindus laurifolius leaf extract in Wistar rats
by: C. N. Santhosh Kumar, et al.
Published: (2013-10-01)

Protective Roles of Green Extract Zinc Oxide Nanoparticles on Monosodium Glutamate-Induced Hepatotoxicity and Nephrotoxicity in Female Rats.
by: Azheen Abdulrahman, et al.
Published: (2025-01-01)

Evaluation of Biochemical Parameters of Ethanolic Extract of Lepidium meyenii in Male Wistar Rats
by: Hamdalat Folake Muritala, et al.
Published: (2022-10-01)

Histopathological and the Dose Depended Effects of Aspartame toxicity on Liver and Kidney of Rats
by: Omar Azez, et al.
Published: (2023-04-01)

Identification of Histopathological Changes Induced by Amitraz in Rats
by: Zainab Mohammed, et al.
Published: (2022-10-01)